Varex Imaging(US:VREX)2025-05-08 20:52Q2 FY25 Financial Performance - Revenue increased by 3% from $206 million in Q2 FY24 to $213 million in Q2 FY25[11] - Non-GAAP gross margin improved by 350 basis points, from 33% in Q2 FY24 to 36% in Q2 FY25[12] - Adjusted EBITDA increased by 38% from $25 million in Q2 FY24 to $34 million in Q2 FY25[13] - Non-GAAP diluted EPS increased by 63% from $0.16 in Q2 FY24 to $0.26 in Q2 FY25[15] - Cash, cash equivalents, and marketable securities increased by 19% from $190 million in Q2 FY24 to $226 million in Q2 FY25[16] Revenue Segmentation (Q2 FY25) - Medical segment revenue was $154 million[20] - Industrial segment revenue was $59 million[20] - Americas revenue was $69 million[21] - EMEA revenue was $72 million[21] - APAC revenue was $72 million[21] Q3 FY25 Guidance - Revenue is projected to be between $180 million and $200 million[33] - Non-GAAP EPS is projected to be between -$0.05 and $0.10[33] - Gross margin is expected to be between 32% and 33%[33] - Operating expenses are expected to be approximately $51 million[33]